212 related articles for article (PubMed ID: 37943240)
1. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
J Am Acad Dermatol; 2024 Feb; 90(2):e43-e56. PubMed ID: 37943240
[TBL] [Abstract][Full Text] [Related]
2. Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
J Am Acad Dermatol; 2024 Feb; 90(2):342-345. PubMed ID: 37943241
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Chu AWL; Wong MM; Rayner DG; Guyatt GH; Díaz Martinez JP; Ceccacci R; Zhao IX; McMullen E; Srivastava A; Wang J; Wen A; Wang FC; Brignardello-Petersen R; Izcovich A; Oykhman P; Wheeler KE; Wang J; Spergel JM; Singh JA; Silverberg JI; Ong PY; O'Brien M; Martin SA; Lio PA; Lind ML; LeBovidge J; Kim E; Huynh J; Greenhawt M; Gardner DD; Frazier WT; Ellison K; Chen L; Capozza K; De Benedetto A; Boguniewicz M; Smith Begolka W; Asiniwasis RN; Schneider LC; Chu DK
J Allergy Clin Immunol; 2023 Dec; 152(6):1470-1492. PubMed ID: 37678577
[TBL] [Abstract][Full Text] [Related]
4. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M
Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
[TBL] [Abstract][Full Text] [Related]
5. The evolving atopic dermatitis management landscape.
Sahni VN; Balogh EA; Strowd LC; Feldman SR
Expert Opin Pharmacother; 2022 Mar; 23(4):517-526. PubMed ID: 34758685
[TBL] [Abstract][Full Text] [Related]
6. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
Chu CY
Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
[TBL] [Abstract][Full Text] [Related]
7. Switching between JAK Inhibitors in Patients with Atopic Dermatitis: Unanswered Questions in Daily Clinical Practice.
Mastraftsi S; Bakakis M; Tsiogka A; Afroditi Kleidona I; Gregoriou S
Acta Dermatovenerol Croat; 2023 Dec; 31(3):162-164. PubMed ID: 38439732
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for moderate to severe atopic dermatitis.
Wallace DV
Allergy Asthma Proc; 2022 Nov; 43(6):474-493. PubMed ID: 36335413
[No Abstract] [Full Text] [Related]
9. Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
Sidbury R; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Drucker AM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Davis DMR
J Am Acad Dermatol; 2023 Jul; 89(1):e1-e20. PubMed ID: 36641009
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
; Chu DK; Schneider L; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Wang J; Wheeler KE; Guyatt GH; ; Capozza K; ; Begolka WS; ; Chu AWL; Zhao IX; Chen L; Oykhman P; Bakaa L; ; Golden D; Shaker M; Bernstein JA; Greenhawt M; Horner CC; Lieberman J; Stukus D; Rank MA; Wang J; Ellis A; Abrams E; Ledford D; Chu DK
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):274-312. PubMed ID: 38108679
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
de Graaf M; Janmohamed SR; Schuttelaar MLA; Agner T; Alfonso JH; De Schepper S; Deleuran M; Despontin K; Elenius V; Ghislain PD; Huilaja L; Johansson EK; Kvenshagen BK; Mandelin JM; Olset H; Svensson A; van Tuyll van Serooskerken AM; Thyssen JP; Vestergaard C
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2153-2165. PubMed ID: 35793471
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.
Yim HJ; Jean T; Ong PY
Curr Allergy Asthma Rep; 2024 May; 24(5):289-301. PubMed ID: 38632138
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
14. Atopic dermatitis: phototherapy and systemic therapy.
Davis DM; Borok J; Udkoff J; Lio P; Spergel J
Semin Cutan Med Surg; 2017 Sep; 36(3):118-123. PubMed ID: 28895958
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Treatment of Atopic Dermatitis.
Prezzano JC; Beck LA
Dermatol Clin; 2017 Jul; 35(3):335-349. PubMed ID: 28577803
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis.
Chen Q; Cui L; Hu Y; Chen Z; Gao Y; Shi Y
Heliyon; 2023 Nov; 9(11):e22014. PubMed ID: 38034798
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
[TBL] [Abstract][Full Text] [Related]
18. [Pruritus in atopic dermatitis-comparative evaluation of novel treatment approaches].
Müller S; Witte F; Ständer S
Dermatologie (Heidelb); 2022 Jul; 73(7):538-549. PubMed ID: 35925206
[TBL] [Abstract][Full Text] [Related]
19. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
Wollenberg A; Kinberger M; Arents B; Aszodi N; Avila Valle G; Barbarot S; Bieber T; Brough HA; Calzavara Pinton P; Christen-Zäch S; Deleuran M; Dittmann M; Dressler C; Fink-Wagner AH; Fosse N; Gáspár K; Gerbens L; Gieler U; Girolomoni G; Gregoriou S; Mortz CG; Nast A; Nygaard U; Redding M; Rehbinder EM; Ring J; Rossi M; Serra-Baldrich E; Simon D; Szalai ZZ; Szepietowski JC; Torrelo A; Werfel T; Flohr C
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1409-1431. PubMed ID: 35980214
[TBL] [Abstract][Full Text] [Related]
20. [Current and upcoming treatments of adult atopic dermatitis].
Lacour JP
Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
